FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W213065892> ?p ?o ?g. }

• W213065892 endingPage "62" @default.
• W213065892 startingPage "52" @default.
• W213065892 abstract "To review the comparative efficacy and safety of the proton pump inhibitors (PPIs)--omeprazole, lansoprazole, pantoprazole, and rabeprazole--in the management of acid-related diseases.English-language journal articles retrieved from a MEDLINE search from 1990 to the present using these index terms: proton pump inhibitors, omeprazole, lansoprazole, pantoprazole, rebeprazole, and each of the acid-related diseases.Clinical trials and pertinent review articles that discussed the pharmacology, pharmacokinetics, efficacy, and safety of PPIs in the management of acid-related disease.By the authors.PPIs are substituted benzimidazoles that inhibit gastric acid secretion by covalently binding to the proton pump (H+/K+ ATPase). All undergo extensive hepatic metabolism and conjugation. The four agents differ in their metabolism by and effects on specific hepatic enzymes and thus in their ability to interact with other medications. PPIs are important agents used for eradicating Helicobacter pylori, in treating peptic ulcer disease, gastroesophageal reflux disease, Zollinger-Ellison syndrome, and upper gastrointestinal bleeding, and for preventing acid aspiration. Short-term side effects of the four agents are similar. The long-term safety of pantoprazole and rabeprazole appears similar to that of omeprazole and lansoprazole. Pantoprazole, which is in the final stages of approval for marketing in the United States, will be available in both an oral and injectable formulation.Based on superior efficacy profiles, PPIs are the drugs of choice in managing patients with peptic ulcer disease, gastroesophageal reflux disease, and Zollinger-Ellison syndrome. The decision to select one PPI versus another is most likely to be based on the agents' acquisition costs, formulations, FDA-labeled indications, and overall safety profiles. Intravenous or parenteral pantoprazole may become the preferred antisecretory agent for patients unable to take oral medications (e.g., critically ill patients and those with Zollinger-Ellison syndrome)." @default.
• W213065892 created "2016-06-24" @default.
• W213065892 creator A5019390481 @default.
• W213065892 creator A5054788424 @default.
• W213065892 date "2000-01-01" @default.
• W213065892 modified "2023-10-01" @default.
• W213065892 title "Evaluation of Omeprazole, Lansoprazole, Pantoprazole, and Rabeprazole in the Treatment of Acid-Related Diseases" @default.
• W213065892 cites W10412033 @default.
• W213065892 cites W1531121928 @default.
• W213065892 cites W1657629513 @default.
• W213065892 cites W1965645355 @default.
• W213065892 cites W1968386849 @default.
• W213065892 cites W1971705529 @default.
• W213065892 cites W1972053711 @default.
• W213065892 cites W1976194241 @default.
• W213065892 cites W1985636157 @default.
• W213065892 cites W1985915139 @default.
• W213065892 cites W1986475840 @default.
• W213065892 cites W1989726504 @default.
• W213065892 cites W1990175099 @default.
• W213065892 cites W1992436643 @default.
• W213065892 cites W1994305913 @default.
• W213065892 cites W1995965011 @default.
• W213065892 cites W2001495177 @default.
• W213065892 cites W2002935141 @default.
• W213065892 cites W2004224601 @default.
• W213065892 cites W2006246096 @default.
• W213065892 cites W2009692949 @default.
• W213065892 cites W2019327551 @default.
• W213065892 cites W2020703679 @default.
• W213065892 cites W2021121263 @default.
• W213065892 cites W2027677946 @default.
• W213065892 cites W2028600073 @default.
• W213065892 cites W2028941264 @default.
• W213065892 cites W2031838338 @default.
• W213065892 cites W2036082465 @default.
• W213065892 cites W2036515754 @default.
• W213065892 cites W2036589016 @default.
• W213065892 cites W2037290396 @default.
• W213065892 cites W2038798915 @default.
• W213065892 cites W2040171103 @default.
• W213065892 cites W2041307291 @default.
• W213065892 cites W2042948630 @default.
• W213065892 cites W2042960480 @default.
• W213065892 cites W2043640657 @default.
• W213065892 cites W2046209965 @default.
• W213065892 cites W2048086356 @default.
• W213065892 cites W2051419573 @default.
• W213065892 cites W2052710268 @default.
• W213065892 cites W2052794083 @default.
• W213065892 cites W2061260036 @default.
• W213065892 cites W2067862306 @default.
• W213065892 cites W2069706028 @default.
• W213065892 cites W2076694998 @default.
• W213065892 cites W2080628668 @default.
• W213065892 cites W2085055426 @default.
• W213065892 cites W2092998505 @default.
• W213065892 cites W2094172210 @default.
• W213065892 cites W2094502777 @default.
• W213065892 cites W2103359006 @default.
• W213065892 cites W2112871334 @default.
• W213065892 cites W2113150145 @default.
• W213065892 cites W2125992095 @default.
• W213065892 cites W2126492194 @default.
• W213065892 cites W2130798306 @default.
• W213065892 cites W2145804143 @default.
• W213065892 cites W2150225939 @default.
• W213065892 cites W2158362878 @default.
• W213065892 cites W2223077648 @default.
• W213065892 cites W2313046836 @default.
• W213065892 cites W2313437711 @default.
• W213065892 cites W2314540303 @default.
• W213065892 cites W2333044470 @default.
• W213065892 cites W2369038841 @default.
• W213065892 cites W2402192287 @default.
• W213065892 cites W3023580101 @default.
• W213065892 cites W3192077053 @default.
• W213065892 cites W37300155 @default.
• W213065892 doi "https://doi.org/10.1016/s1086-5802(16)31036-1" @default.
• W213065892 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10665250" @default.
• W213065892 hasPublicationYear "2000" @default.
• W213065892 type Work @default.
• W213065892 sameAs 213065892 @default.
• W213065892 citedByCount "116" @default.
• W213065892 countsByYear W2130658922012 @default.
• W213065892 countsByYear W2130658922013 @default.
• W213065892 countsByYear W2130658922014 @default.
• W213065892 countsByYear W2130658922015 @default.
• W213065892 countsByYear W2130658922016 @default.
• W213065892 countsByYear W2130658922017 @default.
• W213065892 countsByYear W2130658922018 @default.
• W213065892 countsByYear W2130658922019 @default.
• W213065892 countsByYear W2130658922020 @default.
• W213065892 countsByYear W2130658922021 @default.
• W213065892 countsByYear W2130658922022 @default.
• W213065892 countsByYear W2130658922023 @default.
• W213065892 crossrefType "journal-article" @default.
• W213065892 hasAuthorship W213065892A5019390481 @default.

• next